Ad
related to: moderna's covid-19 vaccine stock
Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 15 hours agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...
Gateway - Quartz
Quartz· 2 days agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a ...
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 5 days agoThat's why the company's stock skyrocketed in the earlier days of the pandemic. It's also why its...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 17 hours agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 4 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Market Whales and Their Recent Bets on MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 17 hours agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020 ...
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Zacks via Yahoo Finance· 19 hours agoIntra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight...
GAMMA Investing LLC Purchases 822 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 1 day ago(NASDAQ:MRNA – Free Report) by 37.8% in the first quarter, HoldingsChannel reports. The fund owned 2,994 shares of the company’s stock after acquiring an additional 822 shares ...
